Berlin, Germany

Riad Bourayou

This inventor holds 1 USPTO granted patent. Top assignee: B. Braun Melsungen Ag. Active years: 2020.


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Riad Bourayou: Innovator in Diagnostic Imaging

Introduction

Riad Bourayou is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of diagnostic imaging, particularly through his innovative approaches to the administration of contrast agents.

Latest Patents

Riad Bourayou holds a patent for his invention titled "Pre-saturation of the liver and subsequent administration of the contrast agent." This invention relates to an aqueous formulation designed for use in diagnostic detection. The formulation is administered prior to the introduction of a fluorinated contrast agent, enhancing the effectiveness of diagnostic imaging. The invention also encompasses a method of administration and a diagnostic kit suitable for detecting inflammatory pathological conditions using MR imaging. He has 1 patent to his name.

Career Highlights

Riad Bourayou is associated with B. Braun Melsungen AG, a company known for its commitment to innovation in medical technology. His work at the company has allowed him to focus on developing advanced solutions for diagnostic imaging.

Collaborations

Throughout his career, Riad has collaborated with esteemed colleagues such as Thore Dietrich and Eckart Fleck. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Riad Bourayou's contributions to the field of diagnostic imaging exemplify the impact of innovative thinking in medicine. His patent for the pre-saturation of the liver and the subsequent administration of contrast agents showcases his commitment to improving diagnostic techniques.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…